Skip to main content
Clinical Trials/NCT04519294
NCT04519294CompletedNot Applicable

A Prospective, Randomized Study to Evaluate the Safety and Effectiveness of Steerable Ureteroscopic Renal Evacuation(SURE)Using the CVAC™ Aspiration System Compared to Basketing for the Removal of Renal Calculi Following Laser Lithotripsy

Calyxo, Inc.11 sites in 1 country132 target enrollmentStarted: June 16, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
132
Locations
11
Primary Endpoint
Stone Free Rate (SFR) - Zero Fragments

Study Overview

Brief Summary

The purpose of the study is to compare the effects, good and/or bad, of a treatment for removing kidney stones called the SURE procedure for stone evacuation to the standard treatment using a basket for stone removal.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Candidate for ureteroscopy with laser lithotripsy;
  • Presence of renal stone(s);
  • Be willing and able to return for all study-related follow up procedures; and,
  • Have been informed of the nature of the study, agreeing to its requirements, and have signed the IRB approved informed consent.

Exclusion Criteria

  • BMI > 45;
  • Significant comorbidities;
  • Bladder, ureteral or kidney abnormalities;
  • Pregnant individuals; or
  • Unable to meet the treatment and follow up protocol requirements.

Arms & Interventions

SURE

Active Comparator

Intervention: SURE (Device)

Standard Ureteroscopy (Basketing)

Active Comparator

Intervention: Standard Ureteroscopy (Basketing) (Device)

Outcomes

Primary Outcomes

Stone Free Rate (SFR) - Zero Fragments

Time Frame: 30 Days

The primary efficacy endpoint is the SFR, where stone free status is defined as zero residual fragments at 30 days observed on non-contrast CT (NCCT) (1.25mm slice thickness) by blinded central reviewer(s). The SFR is calculated by determining the number of subjects in each treatment arm with a stone free status of zero fragments and dividing that by the total number of subjects treated in the respective treatment arm.

Secondary Outcomes

  • Residual Stone Volume (RSV)(30 Days)
  • Stone Clearance (% Reduction in Stone Volume)(30 Days)

Investigators

Sponsor
Calyxo, Inc.
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (11)

Loading locations...

Similar Trials